STOCK TITAN

IQM Quantum Computers: MIG Capital reports 7.5% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

IQM Quantum Computers Oyj (IQMX) is the subject of a Schedule 13G reporting beneficial ownership by MIG Capital AG and seven MIG funds. MIG Capital AG reported beneficial ownership of 14,160,070 ordinary shares, or 7.5%, with shared voting and dispositive power as investment manager for the funds. The funds directly hold the shares, and the reporting persons expressly disclaimed group status. The reported percentages use 189,496,218 ordinary shares outstanding as of September 30, 2026.

MIG Capital AG beneficial ownership 14,160,070 ordinary shares Reported as of September 30, 2026
MIG Capital AG ownership percentage 7.5% Based on 189,496,218 ordinary shares outstanding as of September 30, 2026
Ordinary shares outstanding 189,496,218 ordinary shares As of September 30, 2026; basis for reported ownership percentages
beneficial ownership regulatory
"Aggregate amount beneficially owned by each reporting person"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
shared voting power regulatory
"Shared Voting Power"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared Dispositive Power"
American Depositary Shares technical
"CUSIP Number has been assigned to the American Depositary Shares"
American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many IQMX ordinary shares did MIG Capital AG report owning?

MIG Capital AG reported 14,160,070 ordinary shares, or 7.5%, as of September 30, 2026.

Which MIG funds directly hold IQMX shares, and how many?

The direct holdings are MIG GmbH & Co. Fonds 2 KG, 803,151 shares; Fonds 4 KG, 1,551,910; Fonds 6 KG, 1,551,910; Fonds 8 KG, 1,845,280; Fonds 10 KG, 3,048,560; Fonds 14 geschlossene Investment-KG, 3,568,275; and Fonds 17 geschlossene Investment-KG, 1,790,984 ordinary shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





462921107

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



MIG Capital AG
Signature:/s/ Kristian Schmidt-Garve
Name/Title:By Kristian Schmidt-Garve, General Partner
Date:11/19/2026
Signature:/s/ Dr. Matthias Kromayer
Name/Title:By Dr. Matthias Kromayer, General Partner
Date:11/19/2026
MIG GmbH & Co. Fonds 2 KG
Signature:/s/ Kristian Schmidt-Garve
Name/Title:By Kristian Schmidt-Garve, Authorized Signatory
Date:11/19/2026
Signature:/s/ Dr. Matthias Kromayer
Name/Title:By Dr. Matthias Kromayer, Authorized Signatory
Date:11/19/2026
MIG GmbH & Co. Fonds 4 KG
Signature:/s/ Kristian Schmidt-Garve
Name/Title:By Kristian Schmidt-Garve, Authorized Signatory
Date:11/19/2026
Signature:/s/ Dr. Matthias Kromayer
Name/Title:By Dr. Matthias Kromayer, Authorized Signatory
Date:11/19/2026
MIG GmbH & Co. Fonds 6 KG
Signature:/s/ Kristian Schmidt-Garve
Name/Title:By Kristian Schmidt-Garve, Authorized Signatory
Date:11/19/2026
Signature:/s/ Dr. Matthias Kromayer
Name/Title:By Dr. Matthias Kromayer, Authorized Signatory
Date:11/19/2026
MIG GmbH & Co. Fonds 8 KG
Signature:/s/ Kristian Schmidt-Garve
Name/Title:By Kristian Schmidt-Garve, Authorized Signatory
Date:11/19/2026
Signature:s/ Dr. Matthias Kromayer
Name/Title:By Dr. Matthias Kromayer, Authorized Signatory
Date:11/19/2026
MIG GmbH & Co. Fonds 10 KG
Signature:/s/ Kristian Schmidt-Garve
Name/Title:By Kristian Schmidt-Garve, Authorized Signatory
Date:11/19/2026
Signature:/s/ Dr. Matthias Kromayer
Name/Title:By Dr. Matthias Kromayer, Authorized Signatory
Date:11/19/2026
MIG GmbH & Co. Fonds 14 geschlossene Investment-KG
Signature:/s/ Kristian Schmidt-Garve
Name/Title:By Kristian Schmidt-Garve, Authorized Signatory
Date:11/19/2026
Signature:/s/ Dr. Matthias Kromayer
Name/Title:By Dr. Matthias Kromayer, Authorized Signatory
Date:11/19/2026
MIG GmbH & Co. Fonds 17 geschlossene Investment-KG
Signature:/s/ Kristian Schmidt-Garve
Name/Title:By Kristian Schmidt-Garve, Authorized Signatory
Date:11/19/2026
Signature:/s/ Dr. Matthias Kromayer
Name/Title:By Dr. Matthias Kromayer, Authorized Signatory
Date:11/19/2026
Exhibit Information

Exhibit 99.1 Joint Filing Agreement

Keep reading